The mechanisms and pathogenesis of many neurodegenerative diseases such as Alzheimer disease (AD) and Parkinson disease are not completely understood. However, it is hypothesized that clearance of amyloid beta (Ab) aggregates in AD-patient can result in cognitive improvement and reverse the progression of disease. The Ab aggregates should be disrupted into insoluble...